If you’ve started Mounjaro to support your weight loss journey, you might be wondering what to expect each week. Everyone’s experience is slightly different, and understanding how to make the most of your weekly routine can help you stay motivated and see steady results. Mounjaro works best when combined with
Obesity remains a major health concern in the UK, with 26.5% of adults in England now living with obesity, according to the Office for Health Improvement and Disparities (OHID, 2025). This rise highlights a growing public health crisis that increases the risk of diabetes, heart disease, and many other conditions.
With around 64% of adults in England estimated to be overweight or living with obesity, weight-related health concerns are clearly rising and have become a major public health challenge. In this context, weight loss injections such as Wegovy and Mounjaro have gained attention in the UK for helping people lose
Wegovy, a prescription weekly injection of semaglutide, is increasingly used in the UK to support weight loss in individuals with significant obesity. According to the latest national profile, in 2023-24 around 26.5% of adults in England were living with obesity. This high prevalence highlights the importance of safe and effective
Managing diabetes and excess weight often goes hand in hand. In the UK, more than 5.8 million people are living with diabetes — and nearly 1.3 million are thought to be undiagnosed. Many of these cases involve type 2 diabetes, which is closely linked to obesity and metabolic imbalance. This
Losing weight is challenging, and with rising obesity rates in the UK, choosing the right treatment is more important than ever. In 2023-24, 64.5% of adults in England were estimated to be either overweight or living with obesity — and 26.5% were living with obesity alone. Wegovy weight loss injections
One in five adults in the UK now lives with either diabetes or pre-diabetes — that is over 12 million people. Managing type 2 diabetes often means tackling two challenges simultaneously: keeping blood sugar within safe limits and dealing with excess weight. Mounjaro injections are one of the newer treatments
Wegovy injections have quickly become one of the most talked-about treatments for weight loss in the UK. In the SELECT trial (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity), involving over 17,600 adults with overweight or obesity and established cardiovascular disease but no diabetes, Wegovy reduced the
Wegovy for weight loss is arriving at a time when obesity remains a major public health concern in England. According to the latest data, 26.5% of adults in 2023-24 were living with obesity, and about 64.5% were either overweight or obese. Clinical trials such as the STEP programme show that
Obesity is a constantly growing health concern in the UK—recent data shows that 29 per cent of adults in England are living with obesity, and 64 per cent are either overweight or obese. Many are exploring treatments such as Wegovy and Mounjaro. If you are using Wegovy and wondering whether
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 | ||||
@2025 Touchwood Pharmacy. All Right Reserved.
